These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34065978)

  • 1.
    Jones RB; Arenaza L; Rios C; Plows JF; Berger PK; Alderete TL; Fogel JL; Nayak K; Mohamed P; Hwang D; Palmer S; Sinatra F; Allayee H; Kohli R; Goran MI
    Nutrients; 2021 May; 13(5):. PubMed ID: 34065978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased hepatic fat in overweight Hispanic youth influenced by interaction between genetic variation in PNPLA3 and high dietary carbohydrate and sugar consumption.
    Davis JN; Lê KA; Walker RW; Vikman S; Spruijt-Metz D; Weigensberg MJ; Allayee H; Goran MI
    Am J Clin Nutr; 2010 Dec; 92(6):1522-7. PubMed ID: 20962157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Intervention to Reduce Dietary Sugar Does Not Affect Liver Fat in Latino Youth, Regardless of PNPLA3 Genotype: A Randomized Controlled Trial.
    Schmidt KA; Jones RB; Rios C; Corona Y; Berger PK; Plows JF; Alderete TL; Fogel J; Hampson H; Hartiala JA; Cai Z; Allayee H; Nayak KS; Sinatra FR; Harlan G; Pickering TA; Salvy SJ; Mack WJ; Kohli R; Goran MI
    J Nutr; 2022 Jul; 152(7):1655-1665. PubMed ID: 35218194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations of dietary sugars with liver stiffness in Latino adolescents with obesity differ on PNPLA3 and liver disease severity.
    Schenker RB; Machle CJ; Schmidt KA; Allayee H; Kohli R; Goran MI
    Liver Int; 2024 Aug; 44(8):1768-1774. PubMed ID: 38634702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the Association Between PNPLA3 Genetic Variation and Dietary Intake on the Risk of Significant Fibrosis in Patients With NAFLD.
    Vilar-Gomez E; Pirola CJ; Sookoian S; Wilson LA; Belt P; Liang T; Liu W; Chalasani N
    Am J Gastroenterol; 2021 May; 116(5):994-1006. PubMed ID: 33306506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The rs738409 polymorphism of the PNPLA3 gene is associated with hepatic steatosis and fibrosis in Brazilian patients with chronic hepatitis C.
    Manchiero C; Nunes AKDS; Magri MC; Dantas BP; Mazza CC; Barone AA; Tengan FM
    BMC Infect Dis; 2017 Dec; 17(1):780. PubMed ID: 29258449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders.
    Xia MF; Ling Y; Bian H; Lin HD; Yan HM; Chang XX; Li XM; Ma H; Wang D; Zhang LS; Wang SS; Wu BJ; He WY; Zhao NQ; Gao X
    Aliment Pharmacol Ther; 2016 Mar; 43(5):631-42. PubMed ID: 26765961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination of PNPLA3 and TLL1 polymorphism can predict advanced fibrosis in Japanese patients with nonalcoholic fatty liver disease.
    Seko Y; Yamaguchi K; Mizuno N; Okuda K; Takemura M; Taketani H; Hara T; Umemura A; Nishikawa T; Moriguchi M; Yasui K; Kamaguchi M; Nishioji K; Mochizuki N; Kobayashi M; Mori K; Tanaka S; Matsuura K; Tanaka Y; Itoh Y
    J Gastroenterol; 2018 Mar; 53(3):438-448. PubMed ID: 28744823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between non-alcoholic steatohepatitis, PNPLA3 I148M genotype and bone mineral density in adolescents.
    Mosca A; Fintini D; Scorletti E; Cappa M; Paone L; Zicari AM; Nobili V; Byrne CD
    Liver Int; 2018 Dec; 38(12):2301-2308. PubMed ID: 30176114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of PNPLA3 with non-alcoholic fatty liver disease in a minority cohort: the Insulin Resistance Atherosclerosis Family Study.
    Wagenknecht LE; Palmer ND; Bowden DW; Rotter JI; Norris JM; Ziegler J; Chen YD; Haffner S; Scherzinger A; Langefeld CD
    Liver Int; 2011 Mar; 31(3):412-6. PubMed ID: 21281435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrating genetic and socioeconomic data to predict the progression of nonalcoholic fatty liver disease.
    Rieman-Klingler MC; Jung J; Tesfai K; Loomba R; Non AL
    Am J Biol Anthropol; 2024 Aug; 184(4):e24979. PubMed ID: 38778456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated effect of PNPLA3 on hepatic fibrosis by HSD17B13 in Japanese patients with non-alcoholic fatty liver disease.
    Seko Y; Yamaguchi K; Tochiki N; Yano K; Takahashi A; Okishio S; Kataoka S; Okuda K; Umemura A; Moriguchi M; Tanaka S; Mori K; Okanoue T; Itoh Y
    Liver Int; 2020 Jul; 40(7):1686-1692. PubMed ID: 32342668
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic fat accumulation is modulated by the interaction between the rs738409 variant in the PNPLA3 gene and the dietary omega6/omega3 PUFA intake.
    Santoro N; Savoye M; Kim G; Marotto K; Shaw MM; Pierpont B; Caprio S
    PLoS One; 2012; 7(5):e37827. PubMed ID: 22629460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of PNPLA3 on liver fat and metabolic profile in Hispanic children and adolescents.
    Goran MI; Walker R; Le KA; Mahurkar S; Vikman S; Davis JN; Spruijt-Metz D; Weigensberg MJ; Allayee H
    Diabetes; 2010 Dec; 59(12):3127-30. PubMed ID: 20852027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A common variant in PNPLA3 is associated with age at diagnosis of NAFLD in patients from a multi-ethnic biobank.
    Walker RW; Belbin GM; Sorokin EP; Van Vleck T; Wojcik GL; Moscati A; Gignoux CR; Cho J; Abul-Husn NS; Nadkarni G; Kenny EE; Loos RJF
    J Hepatol; 2020 Jun; 72(6):1070-1081. PubMed ID: 32145261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the PNPLA3 I148M polymorphism in nonalcoholic fatty liver disease and fibrosis in Korea.
    Lee SS; Byoun YS; Jeong SH; Woo BH; Jang ES; Kim JW; Kim HY
    Dig Dis Sci; 2014 Dec; 59(12):2967-74. PubMed ID: 25069572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PNPLA3 rs738409 I748M is associated with steatohepatitis in 434 non-obese subjects with hepatitis C.
    Petta S; Vanni E; Bugianesi E; Rosso C; Cabibi D; Cammà C; Di Marco V; Eslam M; Grimaudo S; Macaluso FS; McLeod D; Pipitone RM; Abate ML; Smedile A; George J; Craxì A
    Aliment Pharmacol Ther; 2015 May; 41(10):939-48. PubMed ID: 25801076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.
    Mazo DF; Malta FM; Stefano JT; Salles APM; Gomes-Gouvea MS; Nastri ACS; Almeida JR; Pinho JRR; Carrilho FJ; Oliveira CP
    Ann Hepatol; 2019; 18(3):466-471. PubMed ID: 31054980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of diabetes and PNPLA3 genetic variants with disease severity of patients with chronic hepatitis C virus infection.
    Huang CF; Dai CY; Yeh ML; Huang CI; Tai CM; Hsieh MH; Liang PC; Lin YH; Hsieh MY; Yang HL; Huang JF; Lin ZY; Chen SC; Yu ML; Chuang WL
    J Hepatol; 2015 Mar; 62(3):512-8. PubMed ID: 25457210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PNPLA3 gene polymorphism accounts for fatty liver in community subjects without metabolic syndrome.
    Shen J; Wong GL; Chan HL; Chan HY; Yeung DK; Chan RS; Chim AM; Chan AW; Choi PC; Woo J; Chu WC; Wong VW
    Aliment Pharmacol Ther; 2014 Mar; 39(5):532-9. PubMed ID: 24417250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.